Breast cancer Introduction

 Breast cancer is the cancer for which the evidence of a beneficial role of vitamin D is strong.

Breast cancer is the cancer for which the evidence of a beneficial role of vitamin D is strong. There is ample evidence from numerous ecological (geographical), cross-sectional (pictures in time), prospective (looking forward), and case-control studies (looking forward with a control group), meta-analyses (combination) of such studies, and laboratory investigations of mechanisms. A meta-analysis of prospective studies indicates that breast cancer incidence falls as a power law fit vs. serum 25-hydroxyvitamin D [25(OH)D] level, with lowest risk for those with serum 25(OH)D levels near 150 nmol/L (60 ng/mL). Survival rates after diagnosis are higher for those with higher serum 25(OH)D levels at time of diagnosis.

Breast cancer is one of the most frequent cancers among women in Western developed countries. Important risk factors for breast cancer include a diet high in animal products12, consumption of alcoholic beverages234, reproductive factors54, and night shift work6. Much of the risk for breast cancer comes from integrated lifetime estrogen exposure, either endogenous (produced in the body)78 or exogenous (taken orally)9. A diet high in animal products early in life leads to increased endogenous estrogen production over the entire lifetime. Night shift work is associated with reduced melatonin production, and melatonin can reduce the risk of breast cancer101112.
That vitamin D might reduce the risk of breast cancer was proposed in 1989 based on effects on breast cancer cell proliferation13. Ecological studies (populations defined geographically) using indices for solar ultraviolet-B (UVB) dose followed quickly1415. Since then, there have been numerous ecological and observational studies of incidence and mortality rates with respect to solar ultraviolet-B (UVB) irradiance, serum 25(OH)D levels, and oral vitamin D intake.

Page last edited: 22 August 2011


  1. Armstrong, B. Doll, R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer. 1975 Apr 15; 15 (4): 617-31.
  2. Grant, W. B. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer. 2002 Mar 15; 94 (6): 1867-75.
  3. Key, J. Hodgson, S. Omar, R. Z. Jensen, T. K. Thompson, S. G. Boobis, A. R. Davies, D. S. Elliott, P. Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues. Cancer Causes Control. 2006 Aug; 17 (6): 759-70.
  4. Wrensch, M. Chew, T. Farren, G. Barlow, J. Belli, F. Clarke, C. Erdmann, C. A. Lee, M. Moghadassi, M. Peskin-Mentzer, R. Quesenberry, C. P., Jr. Souders-Mason, V. Spence, L. Suzuki, M. Gould, M. Risk factors for breast cancer in a population with high incidence rates. Breast Cancer Res. 2003; 5 (4): R88-102.
  5. Reeves, G. K. Pirie, K. Green, J. Bull, D. Beral, V. Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis. Br J Cancer. 2009 Feb 10; 100 (3): 538-44.
  6. Megdal SP, Kroenke CH, Laden F, Pukkala E, Schernhammer ES. Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer. 2005 Sept; 41 (13): 2023-32.
  7. Key, T. Appleby, P. Barnes, I. Reeves, G. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002 Apr 17; 94 (8): 606-16.
  8. Key, T. J. et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst. 2003 Aug 20; 95 (16): 1218-26.
  9. Coombs, N. J. Cronin, K. A. Taylor, R. J. Freedman, A. N. Boyages, J. The impact of changes in hormone therapy on breast cancer incidence in the US population. Cancer Causes Control. 2010 Jan; 21 (1): 83-90.
  10. Oh, E. Y. Ansell, C. Nawaz, H. Yang, C. H. Wood, P. A. Hrushesky, W. J. Global breast cancer seasonality. Breast Cancer Res Treat. 2010 Aug; 123 (1): 233-43.
  11. Schernhammer, E. S. Hankinson, S. E. Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses’ Health Study cohort. Cancer Epidemiol Biomarkers Prev. 2009 Jan; 18 (1): 74-9.
  12. Stevens, R. G. Light-at-night, circadian disruption and breast cancer: assessment of existing evidence. Int J Epidemiol. 2009 Aug; 38 (4): 963-70.
  13. Colston, K. W. Berger, U. Coombes, R. C. Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet. 1989 Jan 28; 1 (8631): 188-91.
  14. Garland, C. F. Gorham, E. D. Mohr, S. B. Garland, F. C. Vitamin D for cancer prevention: global perspective. Ann Epidemiol. 2009 Jul; 19 (7): 468-83.
  15. Gorham, E. D. Garland, F. C. Garland, C. F. Sunlight and breast cancer incidence in the USSR. Int J Epidemiol. 1990 Dec; 19 (4): 820-4.